Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Prostaglandin analogs like Latanoprost might help grow hair on the scalp and body.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Blocking a protein called prostaglandin D2 might help treat hair loss.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

GPR40 agonists help hair growth through the protein ANGPTL4.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

A new drug strategy improves hair loss treatment with better results and safety.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.